Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study

By sjmartinez • November 14, 2024

Berg JI, Nielsen SM, Malm E, Ioannidis JPA, Furst DE, Smolen JS, Taylor PC, Kristensen LE, Tarp S, Ellingsen T, Christensen R. Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study. Ann Rheum Dis. 2024 Nov 8:ard-2024-226129. doi: 10.1136/ard-2024-226129. Epub ahead of print. PMID: 39521451.

Tags: Arthritis, Axial Spondyloarthritis, biological therapy, Epidemiology, Psoriatic, Publications, Rheumatoid, Rheumatology

Prediction of Early Neoadjuvant Chemotherapy Response of Breast Cancer through Deep Learning-based Pharmacokinetic Quantification of DCE MRI

Wu C, Wang L, Wang N, Shiao S, Dou T, Hsu YC, Christodoulou AG, Xie Y, Li D. Prediction of Early Neoadjuvant Chemotherapy Response of[...]

Guideline-directed medical therapy and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: analysis of two nationwide retrospective cohort studies

Jin Z, Aa G, Guo Y, Liu H, Sun H, Li Z, Ma M, Fonarow G, Gao Y, Zhao D, Yang Q, Zhou X; CCC-AF[...]

Three-Dimensional Printing of the Human Pericardium to Facilitate Understanding of the Pericardial Reflections, Recesses, and Sinuses

Miyazaki Y, Rimmer M, Peacock WJ, Xu S, Shivkumar K, Mori S. Three-Dimensional Printing of the Human Pericardium to Facilitate Understanding of the Pericardial Reflections,[...]